Lyfnua (gefapixant) / Merck (MSD) 
Welcome,         Profile    Billing    Logout  
 1 Disease   2 Trials   2 Trials   353 News 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lyfnua (gefapixant) / Merck (MSD)
2019-002308-42: Ph3B recently diagnosed cough in adults

Not yet recruiting
3
414
Europe, RoW
MK-7264, Film-coated tablet
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc
Chronic Cough, Chronic Cough, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
2019-002321-29: Efficacy of Gefapixant in Women with Chronic Cough and Stress Urinary Incontinence

Not yet recruiting
3
380
Europe, RoW
MK-7264, Film-coated tablet
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc
Chronic Cough and Stress Urinary Incontinence, Chronic Cough and Stress Urinary Incontinence, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
2015-002034-47: A study to determine the effect of AF-219 on the urge to cough in patients with long-term cough

Not yet recruiting
2
36
Europe
AF-219, Tablet
Afferent Pharmaceuticals, Inc., Afferent Pharmaceuticals, Inc.
Chronic cough, Long-term cough, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
NCT05813223: Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough

Recruiting
1
31
RoW
Gefapixant, Merck (MK)-7264
Stuart Mazzone, Merck Sharp & Dohme LLC, Melbourne Health, Monash University
Chronic Cough
10/25
06/26
RESTORE, NCT06542484: The Real-world Treatment Satisfaction by Gefapixiant in RCC

Recruiting
N/A
63
Japan
Gefapixant Citrate, LYFNUA Tablets
Nagoya City University, Merck Sharp & Dohme LLC
Chronic Cough
03/26
06/26

Download Options